On 16 December 2020 the National Council for Private Insurance (CNSP) – the Brazilian entity in charge of policy making for the reinsurance sector – issued CNSP Resolution 396/2020. The resolution introduces into the Brazilian market special purpose local reinsurers (SPLRs) and insurance-linked securities (ILS), to be issued by SPLRs.
Background
The resolution, which was issued after a long discussion with market players, dating from 2018, and after two sets of public consultations (Public Consultations 14/2020 and 20/2020), is another step forward by the insurance authorities, which are committed to modernising the Brazilian market, albeit under regulatory supervision.
Eligibility
Pursuant to the resolution, in order to be licensed to operate as an SPLR companies must meet all of the regulatory requirements imposed on local reinsurers. The local reinsurer is the highest level of three types of reinsurance licence under Brazil s tri-licence system (ie, local, admitted and o
Introduction
On 15 February 2021 the Federal Court of Appeal dismissed an appeal of the Federal Court s trial decision in
Loblaws Inc v Columbia Insurance Company (2019 FC 961). Pampered Chef, a Berkshire Hathaway company and a world leader in premium kitchenware products, had previously successfully defended a claim brought by Canada s largest retailer, Loblaws, for:
trademark infringement;
dilution and depreciation of goodwill.
The claim concerned Pampered Chef s use of a trademark that included the letters P and C (for further details please see Pampered Chef succeeds in trademark infringement battle ).
Facts
In the 1980s Loblaws launched its private label brand, President s Choice
, and the companion brand PC in connection with food and grocery products. Over time, Loblaws s use of the PC mark expanded into a range of products and services, including:
Over the next few years, some of the best-known biologic medicines will lose patent protection, paving the way for biosimilar medicines to enter the UK market. This article discusses some innovative IP strategies which may be available in the United Kingdom to successfully compete and overcome barriers to market entry.
Biologic and biosimilar medicines Biosimilars are medicines that seek to compete with, and are similar to, originator biologic products. Biologics contain active substances that are derived from biological sources and are often large, complex molecules such as antibodies.
Biologics are some of the most profitable and widely prescribed medicines. As an example, Adalimumab (Humira), which is used to treat various conditions including rheumatoid arthritis and Crohn s disease, is currently the world s best-selling prescription drug. It is therefore unsurprising that the biosimilars market is highly competitive and is expected to experience substantial growth in the co
What is an advance healthcare directive?
An advance healthcare directive is also known as a living will . Although not a new concept, it is newly recognised in the Cayman Islands.
In 2019 the Health Care Decisions Act was implemented in the Cayman Islands. This law allows individuals to determine their wishes surrounding medical care and treatment, including end-of-life care, should they become mentally incompetent, and prepare a legal document to this effect. The legal document outlines preferred medical treatments and procedures, such as life support and resuscitation.
Advance directives have been around for some time in other jurisdictions, including the United Kingdom, the Unites States, Australia, Canada, South Africa and Jamaica.
The Biden administration has hit the ground running, issuing a flurry of executive orders, actions and memoranda with sweeping implications affecting a wide range of key issues. Companies should look internally and evaluate risks with particular consideration for administration priorities. This risk assessment can help to inform updates to compliance protocols. This article discusses where the administration is likely to focus its civil and criminal enforcement efforts in the months and years ahead.